跳至主要内容
临床试验/NCT04853563
NCT04853563Unknown不适用

Comparison of High VErsus Low Positive End-Expiratory Pressure in Mechanically Ventilated Patients With Acute Heart Failure (HELP-AFH) : Open-label Randomized Controlled Multi-center Pilot Study

Asan Medical Center2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2021年4月20日最近更新:
适应症

试验速览

阶段
不适用
入组人数
120
试验地点
2
主要终点
Ventilator-free day at 28-day

研究概览

简要总结

Little is known about optimal level of positive end-expiratory pressure (PEEP) in patiens who recieved invasive mechanical ventilation for acute decompensated heart failure. We therefore sought to compare clinical outcome according to low versus high PEEP.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject who was diagnosed with congestive heart failure and objective evidence of pulmonary congestion (pulmonary edema on simple chest radiography or positive B-line on lung ultrasonography AND elevated B-type natriuretic peptide or N-terminal pro-brain natriuretic peptide level) as a reason for invasive mechanical ventilation
  • Age over 19 years old
  • Subject who agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethical Committee of the clinical site.

排除标准

  • Subject who are on mechanical circulatory support (ECMO, intra-aortic balloon pump, VAD) at the time of randomization
  • Subject who has cardiac abnormality that requires emergent or urgent percutaneous or surgical valvular procedure
  • Subject who are on vasoactive or inotropic agents at least moderate dose defined as vasoactive-inotropic score >10
  • Isolated preload-dependent cardiac dysfunction (isolated right ventricular failure, right ventricular infarction, constrictive pericarditis, cardiac tamponade, severe pulmonary hypertension without LV dysfunction)
  • Predominant right ventricular failure defined as following; clinical evidence of right ventricular failure by attending physician's discretion including hepatojugular reflux, Kussmaul sign, cardiac liver cirrhosis, hepato/splenomegaly, acites, thronmbocytopenia, etc.
  • Subject who are not on mechanical ventilation before open heart surgery
  • Subject who received unwitness cardiopulmonary rescucitation (CPR) or witness CPR lasting more than 30 minutes
  • Subject who was already diagnosed or is suspected to have hypertophic cardiomyopathy with significant left ventricular outflow tract (LVOT) obstruction
  • Subject with intracranial hemorrahge or ischemic stroke at the time of randomization
  • Subject with irreversible neurologic damage or irreversible hepatic failure
  • Invasive mechanical ventilation lasting more than 24 hours preceding endotracheal intubation
  • Subject with underlying chronic obstructive pulmonary disease (GOLD classification III or IV) or restrictive pulmonary disease (e.g. interstitial lung disease)
  • Subject with impaired consciousness that can not perform self coughing and need suction to maintain adequate airway patency
  • Pregnant and/or lactating women
  • Subject with life expectancy less than a year
  • Subject who is not suitable to enrollment by investigator's discretion

结局指标

主要结局

Ventilator-free day at 28-day

时间窗: up to 28-day

Starting at the day of randomization, and the days on non-invasive ventilation do not count. Successful extubation is defined as at least 24 hours wihtout reintubation independent of invasive assisted ventilation in survivor. Non-survivor within 28 days: ventilator-free day counted as 0, ventilator-free day among only survivor at 28-day will be counted for primary endpoint.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Min-Seok Kim

professor of medicine

Asan Medical Center

研究点 (2)

Loading locations...

相似试验